Renin-Angiotensin-Aldosterone System Inhibitors and Development of Gynecologic Cancers: A 23 Million Individual Population-Based Study

The chronic receipt of renin-angiotensin-aldosterone system (RAAS) inhibitors including angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) have been assumed to be associated with a significant decrease in overall gynecologic cancer risks. This study aimed to in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Nhi Thi Hong, Nguyen, Phung-Anh, Huang, Chih-Wei, Wang, Ching-Huan, Lin, Ming-Chin, Hsu, Min-Huei, Bao, Hoang Bui, Chien, Shuo-Chen, Yang, Hsuan-Chia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968233/
https://www.ncbi.nlm.nih.gov/pubmed/36835224
http://dx.doi.org/10.3390/ijms24043814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968233/
https://www.ncbi.nlm.nih.gov/pubmed/36835224
http://dx.doi.org/10.3390/ijms24043814

Ejemplares similares